FDA Risk Management Tool: Physician Rapid Response Surveys
Physician rapid response surveys of physicians will help FDA make risk management decisions
You may also be interested in...
FDA should consult companies prior to launching a rapid response survey concerning their products, GlaxoSmithKline said in comments to the agency
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011